By: Kevin Cho
Tustin, CA - Integrium, LLC announced they will be attending the 20th Annual Global Investment sponsored by H.C. Wainwright & Co. on September 4-6 at St. Regis, New York, NY. Integrium is looking forward to joining other industry thought leaders and pharmaceutical companies in the Microcap space to fulfill networking goals and potential partnerships.
This event will allow gain of exposure to new and existing Microcap companies. Integrium helps Biotechnology, Pharmaceutical, and Medical Device companies to conserve cash and gain an additional shot-on-goal while waiting for larger ongoing clinical trials to complete.
Integrium Executives will be taking meetings throughout the event and encourage guests to schedule meeting requests with Mark Powers, Executive Director of Capital Solutions. Please contact firstname.lastname@example.org to schedule time with Integrium during the event.
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Innovator and Generic space attain clinical data so they can raise the next round of capital. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs and Oncology.
Check out our new website!
To learn more about Integrium, contact:
Business Development Analyst